Table 1 Patient characteristics
n (%) Total n = 54 | |
|---|---|
Age | |
Median (years, median, range) | 51 (20–65) |
Pathology, n (%) | |
SCC | 44 (79%) |
CAC | 10 (21%) |
FIGO stage, n (%) | |
I | 18 (33%) |
II | 14 (26%) |
III | 21 (39%) |
IV | 1 (2%) |
Radiotherapy days | |
Median (days, median, range) | 36 (31–45) |
PTV prescription dose | |
Median (Gy, median, range) | 50 (45-50.4) |
WBC at pre-RT (×10^9/L, median, range) | 6 (3.19–9.52) |
ANC at pre-RT (×10^9/L, median, range) | 4 (1.72–8.21) |
ALC at pre-RT (×10^9/L, median, range) | 1.4 (0.53–2.74) |
PLT at pre-RT (×10^9/L, median, range) | 244 (113–471) |
HGB at pre-RT (g/L, median, range) | 120 (87–144) |